ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 95 filers reported holding ACLARIS THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 3.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,579,000 | +276.8% | 263,595 | +365.3% | 0.00% | +100.0% |
| Q4 2018 | $419,000 | -70.1% | 56,651 | -41.3% | 0.00% | 0.0% |
| Q3 2018 | $1,402,000 | +45.3% | 96,580 | +99.8% | 0.00% | 0.0% |
| Q2 2018 | $965,000 | +30.1% | 48,336 | +14.2% | 0.00% | 0.0% |
| Q1 2018 | $742,000 | -28.5% | 42,335 | +0.6% | 0.00% | 0.0% |
| Q4 2017 | $1,038,000 | +3.6% | 42,099 | +8.4% | 0.00% | 0.0% |
| Q3 2017 | $1,002,000 | +0.5% | 38,826 | +5.6% | 0.00% | 0.0% |
| Q2 2017 | $997,000 | +67.6% | 36,751 | +84.0% | 0.00% | 0.0% |
| Q1 2017 | $595,000 | +27.1% | 19,968 | +15.8% | 0.00% | 0.0% |
| Q4 2016 | $468,000 | +32.2% | 17,249 | +24.9% | 0.00% | 0.0% |
| Q3 2016 | $354,000 | +35.1% | 13,814 | -2.8% | 0.00% | – |
| Q2 2016 | $262,000 | +85.8% | 14,212 | +91.0% | 0.00% | – |
| Q1 2016 | $141,000 | -7.8% | 7,440 | +30.8% | 0.00% | – |
| Q4 2015 | $153,000 | – | 5,687 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 441,000 | $833,000 | 2.78% |
| MFN Partners Management, LP | 4,000,000 | $7,560,000 | 1.56% |
| Endurant Capital Management LP | 2,055,069 | $3,884,000 | 1.22% |
| Broadfin Capital, LLC | 1,888,039 | $3,568,000 | 0.48% |
| Aisling Capital Management LP | 634,455 | $1,199,000 | 0.46% |
| EcoR1 Capital, LLC | 2,087,312 | $3,945,000 | 0.36% |
| Sofinnova Investments, Inc. | 1,911,573 | $3,613,000 | 0.26% |
| Alambic Investment Management, L.P. | 115,036 | $217,000 | 0.18% |
| Parkman Healthcare Partners LLC | 225,000 | $425,000 | 0.12% |
| Rock Springs Capital Management LP | 1,600,000 | $3,024,000 | 0.10% |